GTH 4.02 (+0%)
US37186H1005Medical Diagnostics & ResearchDiagnostics & Research

Genetron Holdings (GTH) Competitor Comparison

We are evaluating the key criteria listed to compare Genetron Holdings (GTH) against its competitors in the Diagnostics & Research industry.

Linearity 5 years - GTH ranking 0 / 58

These are the competitors of Genetron Holdings in the industry Diagnostics & Research ranked by linearity 5 years
1. Twist Bioscience TWST
1.05K
2. Qiagen QGEN
1.04K
3. Co-Diagnostics CODX
100.26
4. Ortho Clinical Diagnostics Holdings OCDX
33.4
5. DarioHealth DRIO
31.71
6. IQVIA Holdings IQV
30.01
7. Icon ICLR
26.89
8. Syneos Health SYNH
24.79
9. Fulgent Genetics FLGT
21.51
10. Heska HSKA
15.42
11. Thermo Fisher Scientific TMO
11.92
12. Charles River Laboratories CRL
11.9
13. Pacific Biosciences of California PACB
11.24
14. Inotiv NOTV
11.01
15. DexCom DXCM
9.29
16. Agilent Technologies A
8.67
17. Olink Holding OLK
8.53
18. Precipio PRPO
7.84
19. Danaher DHR
7.5
20. Myriad Genetics MYGN
7.07
21. Anixa Biosciences ANIX
6.36
22. Exact Sciences EXAS
5.98
23. Aspira Womens Health AWH
5.9
24. Mettler-Toledo MTD
5.83
25. CareDx CDNA
5.83
26. PerkinElmer PKI
4.97
27. Trinity Biotech TRIB
4.91
28. IDEXX Laboratories IDXX
4.46
29. Psychemedics PMD
4.1
30. Personalis PSNL
3.97
31. Enzo Biochem ENZ
3.59
32. Guardant Health GH
3.5
33. Sotera Health SHC
3.35
34. NeoGenomics NEO
3.32
35. Laboratory Corp of America Holdings LH
3.17
36. Quest Diagnostics DGX
3.16
37. Illumina ILMN
3.09
38. Waters WAT
2.9
39. Neogen NEOG
2.89
40. National Research NRC
2.77
41. Bioventus BVS
2.74
42. Exagen XGN
2.45
43. Interpace Biosciences IDXG
2.45
44. Sera Prognostics SERA
2.3
45. Neuronetics STIM
2.28
46. Global Cord Blood CO
2.23
47. MDxHealth MDXH
1.91
48. Biodesix BDSX
1.8
49. MaxCyte MXCT
1.8
50. Prenetics Global PRE
1.71
51. bioAffinity Technologies BIAF
1.67
52. Organovo Holdings ONVO
1.6
53. SeqLL SQL
1.38
54. Medpace Holdings MEDP
1.13
55. Meridian Bioscience VIVO
0.99
56. RadNet RDNT
0.77
57. Natera NTRA
0.7
58. Lantheus Holdings LNTH
0.25

Obligatory risk notice

We would like to point out that the contents of this website are for general information purposes only and do not constitute recommendations for the purchase or sale of specific financial instruments, and therefore do not constitute investment advice. In particular, marketstorylabs.com and its creators cannot assess the extent to which information / recommendations made on the pages correspond to your investment objectives, your risk tolerance and your ability to bear losses. Therefore, if you make any investment decisions based on information on the site, you do so solely on your own responsibility and at your own risk. This in turn means that neither marketstorylabs.com nor its creators are liable for any losses incurred as a result of investment decisions based on the information on the marketstorylabs.com website or other media used.